About Us
Novici Biotech LLC (Novici) was formed in July 2007. The company acquired GRAMMR, a proprietary molecular evolution platform, to generate competitively superior biotechnology products. Our technology is applicable in a number of product categories and markets including biopharmaceutical applications, biocatalysis, and agricultural biotechnology.
Although Novici is a new biotech company, we are in a relatively unique position as a start-up company, holding patents, a proven technology platform, and an early-stage product portfolio. We seek opportunities with companies interested in superior molecular evolution technology and to partner the commercialization of our own proprietary product candidates. Due to the wide applicability of our technology, we look forward to working with companies in various fields developing novel products as well as improving existing ones.